Feasibility of Single Time Point Dosimetry Application in 177Lu-DOTATATE/DOTATOC-treated Pediatric Neuroblastoma
The findings confirm that the 96 hours STP H method can reliably replace MTP for dosimetric assessment in pediatric NB patients treated with 177 Lu-DOTATATE and performed well in renal dosimetry for 177 Lu-DOTATOC therapy.
Authors
- Pengfei Li (ORCID: https://orcid.org/0000-0002-4847-8180)
- Han Wang (ORCID: https://orcid.org/0000-0001-8042-1232)
- Yuxuan Liu (ORCID: https://orcid.org/0000-0003-4426-9290)
- Yingying Sun (ORCID: https://orcid.org/0000-0003-2633-5784)
- Xiaorong Sun (ORCID: https://orcid.org/0000-0002-3266-3023)
- Xingyao Sun
- Fei Zheng (ORCID: https://orcid.org/0000-0003-2407-5149)
- Hao Yang (ORCID: https://orcid.org/0009-0007-7437-1815)
Institutions
- Academy of Medical Sciences (GB)
- Shandong Tumor Hospital (CN)
- Jinan City People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1097/rlu.0000000000006029
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00